Abstract
Protein kinase B (PKB) is an important intermediate in the phosphatidylinositol-3 kinase signaling cascade that acts to phosphorylate glycogen synthase kinase-3 (GSK-3) at its serine 9 residue, thereby inactivating it. Activated GSK-3 has been previously shown to be preferentially associated with neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) brain. In the present study, we performed immunohistochemistry with an antibody to the active form of PKB in brains with different stages of neurofibrillary degeneration. We found that the amount of activated PKB (p-Thr308) increased in correlation to the progressive sequence of AT8 immunoreactivity and neurofibrillary changes assessed according to Braak's criteria. By confocal microscopy, activated PKB (p-Thr308) was found to appear in particular in neurons that are known to later develop NFTs in AD. Western blotting showed that activated PKB was increased by more than 50% in the 16,000-g supernatants of AD brains as compared with normal aged and Huntington's disease controls. This increase in PKB levels corresponded with a several-fold increase in the levels of total tau and abnormally hyperphosphorylated tau at the Tau-1 site. These studies suggest the involvement of PKB/GSK-3 signaling in Alzheimer neurofibrillary degeneration.
Similar content being viewed by others
References
Alessi DR, Cohen P (1998) Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 8:55–62
Alonso A del C, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filament and disassembles microtubules. Nat Med 2:783–787
Alonso A del C, Grundke-Iqbal I, Barra HS, Iqbal K (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 94:298–303
Alonso A del C, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98:6923–6928
Atzori C, Ghetti B, Piva R, Srinivasan AN, Zolo P, Delisle MB, Mirra SS, Migheli A (2001) Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol 60:1190–1197
Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, Lee CM (2000) Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 97:11074–11079
Braak E, Braak H (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259
Braak E, Strotkamp B, Braak H (1991) Parvalbumin immunoreactive structures in the hippocampus of the human adult. Cell Tissue Res 264:33–48
Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567
Braak H, Braak E, Ohm T, Bohl J (1988) Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol 63:197–200
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868
Campbell SK, Switzer RC, Martin TL (1987) Alzheimer's plaques and tangles: a controlled and enhanced silver-staining method. Soc Neurosci Abstr 13:H678
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321
Cheng CM, Reinhardt RR, Lee WH, Joncas G, Patel SC, Bondy CA (2000) Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc Natl Acad Sci USA 97:10236–10241
Cohen P, Alessi DR, Cross DAE (1997) PDK1, one of the missing links in insulin signal transduction. FEBS Lett 410:3–10
Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P (1994) The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303:21–26
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings B (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–789
Fiore RS, Bayer VE, Pelech SL, Posada J, Cooper JA, Baraban JM (1993) p42 mitogen-activated protein kinase in brain: prominent localization in neuronal cell bodies and dendrites. Neuroscience 55:463–472
Gallyas F (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 19:1–8
Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer's disease brain. J Neurochem 61:921–927
Gong C-X, Shaikh S, Wang J-Z, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Phosphatase activity toward abnormally phosphorylated τ: decrease in Alzheimer disease brain. J Neurochem 65:732–738
Grundke-Iqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaide MS, Wisniewski HM (1986) Microtubule-associated protein tau, a component of Alzheimer paired helical filaments. J Biol Chem 261:6084–6089
Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder I (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeleton pathology. Proc Natl Acad Sci USA 83:4913–4917
Hanger D, Hughes K, Woodgett JR, Brion J-P, Anderton BH (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147:58–62
Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR (1993) Modulation of glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 12:803–808
Iqbal K, Grundke-Iqbal I (1992) Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Mol Neurobiol 5:399–410
Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B (1986) Defective brain microtubule assembly in Alzheimer disease. Lancet II:421–426
Ishiguro K, Ihara Y, Uchida T, Imahori K (1988) A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau. J Biochem (Tokyo) 104:319–321
Khatoon S, Grundke-Iqbal I, Iqbal K (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59:750–753
Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351:80–84
King CC, Zenke FT, Dawson PE, Dutil EM, Newton AC, Hemmings BA, Bokoch GM (2002). Sphingosine is a novel activator of 3-phosphoinositide-dependent kinase 1. J Biol Chem 275:18108–18113
Kitagawa H, Warita H, Sasaki C, Zhang WR, Sakai K, Shiro Y, Mitsumoto Y, Mori T, Abe K (1999) Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain. Neurosci Lett 274:45–48
Köpke E, Tung Y-C, Shaikh S, Alonso A del C, Iqbal K, Grundke-Iqbal I (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374–24384
Lesort M, Jope RS, Johnson GVW (1999) Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3β and fyn tyrosine kinase. J Neurochem 72:576–584
Lovestone S, Hugh-Reynolds C, Latimer D, Davis DR, Anderton BH, Gallo J-M, Hanger D, Mulot S, Marquaedt B, Stabel S, Woodgett JR, Miller CCJ (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Cell Biol 4: 1077–1086
Mandelkow E-M, Drewes G, Biernat J, Gustke N, Lint J, Vandenheede JR van, Mandelkow E (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associate protein tau. FEBS Lett 314:315–321
Martin D, Salinas M, Lopez-Valdaliso R, Serrano E, Recuero M, Cuadrado A (2001) Effect of the Alzheimer amyloid fragment Abeta (25–35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem 78:1000–1008
Meisinger J, Patel S, Vellody K, Bergstrom R, Benefield J, Lozano Y, Young MR (1997) Protein phosphatase-2A association with microtubules and its role in restricting the invasiveness of human head and neck squamous cell carcinoma cells. Cancer Lett 111:87–95
Moule SK, Welsh GI, Edgell NJ, Foulstone EJ, Pround CG, Denton RM (1997) Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and β-adrenergic agonists in rat epididymal fat cells. J Biol Chem 272:7713–7719
Murai H, Okazaki M, Kikuchi A (1996) Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett 392:153–160
Nagy ZS, Esiri MM (1997) Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18:565–571
O'Toole A, Moule SK, Lockyer PJ, Halestrap AP (2001) Tumor necrosis factor-α activation of protein kinase B in WEHI-164 is accompanied by increased phosphorylation of Ser473, but not Thr308. Biochem J 259:119–127
Owada Y, Utsunomiya A, Yoshimoto T, Kondo H (1997) Expression of mRNA for Akt, serine-threonine protein kinase, in the brain during development and its transient enhancement following axotomy of hypoglossal nerve. J Mol Neurosci 9:27–33
Paudel HK (1997) Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of tau protein in vitro. J Biol Chem 272:28328–28334
Pei J-J, An WL (2002) The stress-activated C-jun amino-terminal kinase (JNK) in Alzheimer disease neurofibrillary degeneration. Brain Aging 2:26–33
Pei J-J, Tanaka T, Tung Y-C, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70–78
Pei J-J, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF (1998) Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 797:267–277
Pei J-J, Braak E, Braak H., Grundke-Iqbal I., Iqbal K, Winblad B., Cowburn RF (1999) Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58:1010–1019
Pei J-J, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (2001) Distribution of active forms of C-jun kinase (JNK) and p38 kinase in brains staged with Alzheimer's disease neurofibrillary changes. J Alzheimer's Dis 3:41–48
Pei J-J, Braak H, Gong C-X, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (2002) Up-regulation of cell division cycle (cdc2) in neurons with early stage Alzheimer's disease neurofibrillary changes. Acta Neuropathol 104:369–376
Pei J-J, Braak H, An WL, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K, (in press) Up-regulation of mitogen activated protein kinase kinase and mitogen activated protein kinase is associated with the progression of Alzheimer's disease neurofibrillary degeneration. Mol Brain Res
Pigino G, Paglini G, Ulloa L, Avila J, Caceres A (1997) Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. J Cell Sci 110:257–270
Rane MJ, Coxon PY, Powell DW, Webster R, Klein JB, Pierce W, Ping P, McLeish KR (2001) p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem 276:3517–3523
Reszka AA, Seger R, Diltz CD, Krebs E, Fischer EH (1995) Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92:8881–8885
Sayas CL, Avila J, Wandosell F (2002) Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms. J Neurosci 22:6863–6875
Shaw M, Cohen P, Alessi DR (1997) Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett 416:307–311
Shirazi SK, Wood JG (1993) The protein tyrosine kinase, fyn, in Alzheimer's disease pathology. NeuroReport 4:435–437
Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC (1995) A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell-cycle. J Cell Biol: 1131–1144
Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC (1996) Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 17:1201–1207
Stein TD, Johnson JA (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activtion of cell survival pathways. J Neurosci 22:7380–7388
Su JH, Deng G, Cotman CW (1997) Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 56:86–93
Tsujio I, Tanaka T, Kudo T, Nishikawa T, Shinozaki K, Grundke-Iqbal I, Iqbal K, Takeda M (2000) Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation. FEBS Lett 469:111–117
Vanhaesebroeck A, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346:561–576
Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/Factor A. EMBO J 9:2431–2438
Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K (1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPKI) glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol 92:232–241
Yamamoto-Honda R, Tobe K, Kaburagi Y, Ueki K, Asai S, Yachi M, Shirouzu M, Yodoi J, Akanuma Y, Yokoyama S, Yazaki Y, Kadowaki T (1995) Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-1. J Biol Chem 270:2729–2734
York RD, Molliver DC, Grewal SS, Stenberg PE, McCleskey EW, Stork PJ (2000) Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol Cell Biol 20:8069–8083
Acknowledgements
Financial support was provided by the Swedish Medical Research Council, Gamla Tjänarinnor Foundation, Greta Lindenau-Hansell Foundation, Loo and Hans Ostermans Foundation, Gun and Bertils Stohnes Foundation, Marianne, Marcus Wallebergs Foundation, Swedish Society for Medical Research, SHMF-9, the Deutsche Forschungsgemeinschaft, and NIH grant AG19158.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pei, JJ., Khatoon, S., An, WL. et al. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol 105, 381–392 (2003). https://doi.org/10.1007/s00401-002-0657-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-002-0657-y